Regulating the regulators : using CD25 depletion to enhance immune responses to a model plasmid-based vaccine by Thoma, Michelle C.
Public Abstract
First Name:Michelle
Middle Name:Cathryn
Last Name:Thoma
Adviser's First Name:Daniel
Adviser's Last Name:Hassett
Co-Adviser's First Name:
Co-Adviser's Last Name:
Graduation Term:SS 2008
Department:Microbiology- Medicine 
Degree:MS
Title:Regulating the regulators: Using CD25 depletion to enhance immune responses to a model plasmid-
based vaccine
Due to their ease of production and safety, plasmid-based vaccines have become prime candidates for
both prophylactic and therapeutic human vaccination. In experimental animal models, vaccination with
plasmid DNA expression vectors has been shown to induce robust cellular and humoral immune responses
against a variety of infectious diseases and some cancers. However, DNA vaccines have proven to be
weakly immunogenic in human clinical trials. The poor immunogenicity of DNA vaccines in humans
necessitates the development of novel methods to enhance both cellular and humoral immune responses
against the plasmid-encoded antigen(s). Previous in vivo studies have shown that CD4+CD25+Foxp3+ T
regulatory cells can repress antigen-specific immune responses. We demonstrate here that depletion of
CD25+ cells prior to plasmid vaccination significantly enhances primary and memory T cell responses and
antibody responses to a model DNA vaccine against Lymphocytic choriomeningitis virus. If this approach
can be safely applied to humans it may not only improve the clinical utility of DNA vaccines but also
improve conventional vaccines as well. 
